What is Leerink Partnrs’ Estimate for XENE Q1 Earnings?
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Xenon Pharmaceuticals in a research report issued to clients and investors on Thursday, February 27th. Leerink Partnrs analyst M. Goodman expects that the biopharmaceutical company will earn ($0.97) per share for the quarter. The consensus estimate […]
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Xenon Pharmaceuticals in a research report issued to clients and investors on Thursday, February 27th. Leerink Partnrs analyst M. Goodman expects that the biopharmaceutical company will earn ($0.97) per share for the quarter. The consensus estimate […]
